首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >Note: In Vitro Activities of Six Fluoroquinolones against 250 Clinical Isolates of Mycobacterium tuberculosis Susceptible or Resistant to First-Line Antituberculosis Drugs
【2h】

Note: In Vitro Activities of Six Fluoroquinolones against 250 Clinical Isolates of Mycobacterium tuberculosis Susceptible or Resistant to First-Line Antituberculosis Drugs

机译:注意:六种氟喹诺酮类药物对250例对一线抗结核药物敏感或耐药的结核分枝杆菌临床分离株的体外活性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Two hundred fifty isolates of Mycobacterium tuberculosis were evaluated for susceptibility to ciprofloxacin, ofloxacin, levofloxacin, grepafloxacin, trovafloxacin, and gemifloxacin (SB-265805). Levofloxacin, ciprofloxacin, and grepafloxacin showed the greatest activity (MIC for 90% of strains tested [MIC90] 1 μg/ml), although ofloxacin also showed good activity, with an MIC90 of 2 μg/ml. Trovafloxacin and gemifloxacin showed lower in vitro activity, with MIC90s of 64 and 8 μg/ml, respectively.
机译:评估了250株结核分枝杆菌对环丙沙星,氧氟沙星,左氧氟沙星,格列沙星,曲伐沙星和吉非沙星的敏感性(SB-265805)。左氧氟沙星,环丙沙星和格帕沙星显示出最大的活性(MIC对90%的受测菌株[MIC90] 1μg/ ml),尽管氧氟沙星也显示出良好的活性,MIC90为2μg/ ml。托伐沙星和吉非沙星的体外活性较低,MIC90分别为64和8μg/ ml。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号